clinical T1D research
T1D subjects
beta-cell peptidome
understanding of T1D
Beta-cell function
beta-cell pathophysiology
beta-cell dysfunction
cell death
T1D registries
cure of T1D
INNODIA partners
immune cell subset
beta-cell specific miRNAs
transcriptome of beta
Clinical Sample Network
imaging functional beta-cell mass
T-cell phosphoproteome
single cell analysis of TCR
new onset T1D patients
large network of clinical partners
clinical EU infrastructure
effective clinical interventions
immune cells
samples available
bio-samples
coordinated studies of unique clinical samples
early signs of beta
clinical trial design
novel biomarker discovery
immune activation
access
Immune Hubs
basic research group
Preclinical type
serum proteome
standardized operating procedures
Diverse biological samples
exploration of novel biomarkers
CyTOF
adults
later analysis
longitudinal sample collection
leading European experts
microbiome analysis
fields of basic
therapy of type
tissue collection
Strict standard operating procedures
development of diabetes medicines
arresting type
animal models
at-risk donors
EUnPOD
stools
disease
high-risk subjects
Immunome
EU-wide collection of pancreases
translation-oriented preclinical models
leading pharmaceutical companies
leading public organizations
metabolic phenotyping procedures
large populations of children
basic science researchers
high throughput screening discovery technologies
splice-variants
strong expertise
complementary expertise
spliced  variants
unique historical bio-repositories
active collaboration
at-risk relatives
US-based nPOD initiative
following modules
specific time points
expert partner laboratories
plasma
systems biology
bioinformatics
measuring
blood
epigenome
lncRNA
genotyping
tissues
immunology
flow cytometry
family members
autoAbs
chemokines
T2D
increased risk
important advances
innovative approach
diagnosis
recent years
modified proteins
progress
industry
translating findings
urine
testing
Biobanks
comprehensive collaborative consortium
normoglycemic controls
Translational approaches
combination of existing techniques
Metabolome-Lipidome
lipidomics
metabolomics
potential
trials
regulators
regulation
prevention
establishment
clinicians
recall
break
way
end
individuals
focus